VRTX
Vertex Pharmaceuticals Inc
508.30$
-1.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +77.9% | +64.9% | +46.2% | +22.5% | +36.6% | +49.1% | +22.1% | +17.9% | +10.5% | +11.7% | +9.6% | |
| – | +105.9% | +67.6% | +30.7% | +48.9% | +33.7% | +34.4% | +22.8% | +19.5% | +16.8% | +21.3% | +18.1% | |
| – | +74.6% | +64.5% | +48.4% | +19.2% | +37.0% | +51.3% | +22.0% | +17.7% | +9.6% | +10.3% | +8.2% | |
| – | +16.4% | +5.2% | +26.4% | +6.9% | +23.9% | +4.3% | +66.8% | -13.0% | +19.1% | +14.8% | +3.4% | |
| – | +21.9% | +13.9% | +23.6% | +12.4% | +18.1% | +17.0% | +9.0% | +5.6% | +28.1% | +28.8% | +19.7% | |
| – | +18.3% | +7.8% | +23.0% | +8.4% | +22.2% | +8.3% | +48.9% | -8.9% | +34.8% | +103.6% | -43.4% | |
| – | – | – | +1,140.4% | +415.4% | +88.5% | +138.5% | -2.6% | +54.8% | -11.0% | -106.1% | – | |
| – | +15.6% | -3.3% | -14.9% | -50.8% | +71.5% | -0.6% | +5.8% | -10.9% | -19.5% | -30.6% | -56.5% | |
| – | – | – | – | – | +132.4% | +123.4% | -12.4% | +55.0% | +3.5% | -94.3% | +1,768.5% | |
| – | +336.6% | -45.1% | -744.0% | – | – | +85.8% | -4.2% | +134.5% | -16.5% | +3.1% | -12.0% | |
| – | – | – | – | +695.8% | -43.9% | +130.4% | -13.6% | +41.8% | +9.0% | -114.8% | – | |
| – | – | – | +36.8% | +584.5% | +120.8% | +110.5% | -11.2% | +52.0% | +3.8% | -89.4% | +900.1% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.